NCT03498417View on ClinicalTrials.gov

Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

CompletedOBSERVATIONAL

Enrollment

135

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

July 20, 2018

Study Completion Date

July 20, 2018

Conditions

Graves OphthalmopathyGraves DiseaseAutoimmune Thyroiditis

Interventions

DIAGNOSTIC_TEST

Serum antibodies against the IGF-1R

Measurement of antibodies against the IGF-1R in serum samples by ELISA

Trial Locations (1)

56124

Endocrinology Unit I, University of Pisa, Pisa

All Listed Sponsors

lead

University of Pisa

OTHER

NCT03498417 - Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy | Biotech Hunter | Biotech Hunter